Biliński P - Search Results

1

A clinical utility of a strip test for influenza A/B and comparison with detection by RT PCR.

Miarka M, Horban A, Maliszewska H, Biliński P, Prus-Kowalczuk W. Miarka M, et al. Among authors: bilinski p. Acta Biochim Pol. 2014;61(3):485-7. Epub 2014 Sep 12. Acta Biochim Pol. 2014. PMID: 25210936

2

Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma.

Centkowski P, Brydak L, Machała M, Kalinka-Warzocha E, Błasińska-Morawiec M, Federowicz I, Walewski J, Wegrzyn J, Wołowiec D, Lech-Marańda E, Sawczuk-Chabin J, Biliński P, Warzocha K; Polish Lymphoma Research Group. Centkowski P, et al. Among authors: bilinski p. J Clin Immunol. 2007 May;27(3):339-46. doi: 10.1007/s10875-007-9073-3. Epub 2007 Mar 8. J Clin Immunol. 2007. PMID: 17345151

3

Comparison study for genotyping of a single-nucleotide polymorphism in the tumor necrosis factor promoter gene.

Juszczynski P, Woszczek G, Borowiec M, Kowalski M, Robak T, Biliński P, Salles G, Warzocha K. Juszczynski P, et al. Among authors: bilinski p. Diagn Mol Pathol. 2002 Dec;11(4):228-33. doi: 10.1097/00019606-200212000-00006. Diagn Mol Pathol. 2002. PMID: 12459639

4

Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.

Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Brydak LB, et al. Among authors: bilinski p. Vaccine. 2006 Nov 10;24(44-46):6620-3. doi: 10.1016/j.vaccine.2006.05.100. Epub 2006 Jun 16. Vaccine. 2006. PMID: 16870313

5

Managing water safety in healthcare. Part 2--practical measures and considerations taken for waterborne pathogen control.

Biliński P, Hołownia P, Wojtyła C, Parafińska K, Tomaszewski W, Kapka-Skrzypczak L. Biliński P, et al. Ann Agric Environ Med. 2012;19(4):619-24. Ann Agric Environ Med. 2012. PMID: 23311777 Free article.

6

Public health hazards in Poland posed by foodstuffs contaminated with E. coli O104:H4 bacterium from the recent European outbreak.

Biliński P, Kapka-Skrzypczak L, Posobkiewicz M, Bondaryk M, Hołownia P, Wojtyła A. Biliński P, et al. Ann Agric Environ Med. 2012;19(1):3-10. Ann Agric Environ Med. 2012. PMID: 22462438 Free article.

7

Determining the scale of designer drugs (DD) abuse and risk to public health in Poland through an epidemiological study in adolescents.

Biliński P, Kapka-Skrzypczak L, Jabłoński P. Biliński P, et al. Ann Agric Environ Med. 2012;19(3):357-64. Ann Agric Environ Med. 2012. PMID: 23020024 Free article.

8

Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.

Biliński P, Hołownia P, Kapka-Skrzypczak L, Wojtyła A. Biliński P, et al. Ann Agric Environ Med. 2012;19(4):857-70. Ann Agric Environ Med. 2012. PMID: 23311820 Free article. Review.

9

Epigenetic regulation in drug addiction.

Biliński P, Wojtyła A, Kapka-Skrzypczak L, Chwedorowicz R, Cyranka M, Studziński T. Biliński P, et al. Ann Agric Environ Med. 2012;19(3):491-6. Ann Agric Environ Med. 2012. PMID: 23020045 Free article. Review.

10

Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma.

Lech-Maranda E, Bienvenu J, Broussais-Guillaumot F, Michallet AS, Warzocha K, Biliński P, Boyle P, Coiffier B, Salles G. Lech-Maranda E, et al. Among authors: bilinski p. Arch Immunol Ther Exp (Warsz). 2013 Apr;61(2):165-74. doi: 10.1007/s00005-012-0215-9. Epub 2013 Jan 3. Arch Immunol Ther Exp (Warsz). 2013. PMID: 23283519 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page